Healthtech Startups

Emergency Response Africa provides mobile-enabled emergency medical dispatch and first responder training across Africa to reduce preventable deaths from sudden illness, accidents, and trauma. The service aims to improve emergency response capacity, reduce maternal and neonatal mortality, and support universal health coverage in lower-income countries.

4 investors

Empatica offers an FDA-cleared health monitoring platform combining medical wearables and digital biomarkers to collect continuous, clinical-quality health data from daily life. It serves researchers, clinicians, and pharmaceutical companies for clinical trials and remote patient monitoring across therapeutic areas including neurology and Parkinson's disease.

4 investors

Emulate develops Organ-Chip technology, including 30+ organ models such as liver, brain, and other human tissue chips, used for human-based preclinical drug safety and toxicity testing. It serves pharmaceutical and biomedical researchers as a human-relevant alternative to animal testing, and works closely with the FDA including acceptance into the ISTAND pilot program.

4 investors

Enable Injections develops and manufactures enFuse, a wearable drug delivery device that delivers large volumes of pharmaceutical and biologic therapeutics subcutaneously for patients with chronic diseases. The company serves healthcare providers, payers, and patients by offering a mechanical hands-free alternative to intravenous treatment.

4 investors

Encellin develops next-generation therapies for patients with chronic unmet clinical needs, using technology originating from Dr. Tejal Desai's laboratory at UCSF that combines micro and nanotechnologies with novel drug delivery approaches. The company focuses on therapeutic delivery platforms and cell-based treatments, particularly for diseases including diabetes and autoimmune conditions.

4 investors

EnClear Therapies is a bio/med-tech company developing the EnTrega CSF platform, focused on cerebrospinal fluid-related therapies. It is built by a multidisciplinary team with experience in platform and commercial market development.

4 investors

Encora Therapeutics makes the Encora X1, an FDA-cleared, prescription wrist-worn device that uses mechanical neurostimulation to relieve hand tremors in adults with essential tremor. The device is designed as a non-drug option that can be used alone or alongside existing treatment plans.

4 investors

Endogenex is a clinical-stage medical device company developing the pulsENDO system, which applies non-thermal pulsed electric field to reset the body's metabolic signaling and improve function in people with type 2 diabetes. Developed in partnership with Mayo Clinic, the therapy aims to help patients manage blood glucose levels and slow disease progression.

4 investors

EngageBio develops DNA-based medicines using proprietary non-viral delivery technology to achieve extended therapeutic expression from a single dose with low manufacturing complexity.

4 investors

Enliven Therapeutics is a biopharmaceutical company developing small molecule precision therapeutics, including ELVN-001, a selective active site inhibitor of BCR::ABL1 for patients with chronic myeloid leukemia (CML). It focuses on drug candidates with differentiated profiles across efficacy, tolerability, and dosing for clinical use.

4 investors

Eternal is a personalized health platform that combines wearable data, lab results, and AI coaching to deliver customized podcasts, daily texts, and in-person care for fitness, health, and longevity. The service integrates diagnostics, training, and professional medical oversight for consumers seeking comprehensive health optimization.

4 investors

Eucalyptus operates a group of digital healthcare clinics providing telehealth services to patients, focused on treating complex and chronic conditions and offering preventative care. The company runs consumer telehealth brands (such as Juniper) across multiple markets globally.

4 investors

Ever/Body operates aesthetics centers offering cosmetic and beauty treatments performed by clinical experts, combining in-center procedures with at-home care plans for individual clients. It focuses on science-based, curated aesthetic treatments delivered through a rigorous provider training program.

4 investors

Evergreen Nephrology partners with nephrologists to manage kidney care for patients with kidney disease, focusing on outcomes such as preventing hospitalizations, slowing disease progression, and increasing transplant rates. It operates a value-based kidney care model that supports physicians in coordinating care for their kidney patient populations.

4 investors

Everlab is a health platform offering preventative diagnostics, longevity testing (bloodwork, genetics, and fitness), and access to longevity-trained doctors, dietitians, and physios, with results and care plans tracked in a single app. It serves individual consumers seeking proactive and preventative healthcare across Australia.

4 investors

evolvedMD integrates behavioral health services into primary care settings to improve access to mental health treatment. The company serves primary care practices and their patients seeking integrated care for depression, anxiety, and other mental health conditions.

4 investors

ExcepGen develops biologics, gene therapies, and vaccines using synthetic biology approaches to create therapies that operate outside normal cellular regulation constraints.

4 investors

Exonate is a biotechnology company developing treatments for retinal vascular diseases, with a lead asset (EXN407) intended as a topical therapy for diabetic retinopathy and diabetic macular oedema. The drug is set to enter Phase IIb clinical trials in 2026.

4 investors

Ezra offers advanced MRI-based full-body scans designed to screen for early signs of cancer and hundreds of other medical conditions. The service targets individuals seeking preventive health screening, with scans potentially eligible for HSA/FSA reimbursement.

4 investors

Filu operates veterinary practices offering comprehensive animal care including emergency medicine, surgery, dentistry, internal medicine, and in-house diagnostics with digital imaging. It serves pet owners across German cities including Berlin, Düsseldorf, Frankfurt, Hamburg, Hannover, Köln, and München, with online appointment booking.

4 investors

FinalDose develops a programmable DNA-targeting molecule designed to recognize and destroy cells carrying specific genetic sequences, with initial applications in oncology across cancer types.

4 investors

Flint connects international and U.S.-based healthcare professionals with hospitals and care organizations offering direct employment and pathways to permanent residency, addressing the critical shortage of nurses in the United States. The company provides end-to-end support including matching, licensing guidance, immigration sponsorship, and relocation services.

4 investors

Florence operates an AI-powered trial operations platform that connects research sites with sponsors and life science organizations to run clinical trials from startup through closeout. It offers tools for investigator site files, electronic trial master files, informed consent, contracting, monitoring, and long-term archiving for the clinical research industry.

4 investors

Floreo builds a library of immersive VR lessons designed to help develop social and behavioral regulation skills. Through its Floreo SkillsXP platform, families, therapists, and educators create individualized learning programs for use in and out of clinical settings.

4 investors